Article | Published:

Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands


Neurological disorders develop in most people infected with human immunodeficiency virus type 1 (HIV-1). However, the underlying mechanisms remain largely unknown. Here we report that binding of HIV-1 transactivator (Tat) protein to low-density lipoprotein receptor-related protein (LRP) promoted efficient uptake of Tat into neurons. LRP-mediated uptake of Tat was followed by translocation to the neuronal nucleus. Furthermore, the binding of Tat to LRP resulted in substantial inhibition of neuronal binding, uptake and degradation of physiological ligands for LRP, including α2-macroglobulin, apolipoprotein E4, amyloid precursor protein and amyloid β-protein. In a model of macaques infected with a chimeric strain of simian–human immunodeficiency virus, increased staining of amyloid precursor protein was associated with Tat expression in the brains of simian–human immunodeficiency virus-infected macaques with encephalitis. These results indicate that HIV-1 Tat may mediate HIV-1-induced neuropathology through a pathway involving disruption of the metabolic balance of LRP ligands and direct activation of neuronal genes.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Price, R.W. et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239, 586–592 (1988).

  2. 2

    Lee, S.C. et al. Productive infection of human fetal microglia by HIV-1. Am. J. Pathol. 143, 1032–1039 (1993).

  3. 3

    He, J., deCastro, C.M., Vandenbark, G.R., Busciglio, J. & Gabuzda, D. Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit protooncogene. Proc. Natl. Acad. Sci. USA 94, 3954–3959 (1997).

  4. 4

    Gendelman, H.E., Lipton, S.A., Tardieu, M., Bukrinsky, M.I. & Nottet, H.S. The neuropathogenesis of HIV-1 infection. J. Leukoc. Biol. 56, 389–398 (1994).

  5. 5

    Sabatier, J.M. et al. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65, 961–967 (1991).

  6. 6

    Kruman, II, Nath, A. & Mattson, M.P. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp. Neurol. 154, 276–288 (1998).

  7. 7

    Chang, H.C., Samaniego, F., Nair, B.C., Buonaguro, L. & Ensoli, B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 11, 1421–1431 (1997).

  8. 8

    Ensoli, B. et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277–287 (1993).

  9. 9

    New, D.R., Maggirwar, S.B., Epstein, L.G., Dewhurst, S. & Gelbard, H.A. HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB- independent mechanism. J. Biol. Chem. 273, 17852–17858 (1998).

  10. 10

    Jones, M., Olafson, K., Del Bigio, M.R., Peeling, J. & Nath, A. Intraventricular injection of human immunodeficiency virus type 1 (HIV- 1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J. Neuropathol. Exp. Neurol. 57, 563–570 (1998).

  11. 11

    Rappaport, J. et al. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J. Leukoc. Biol. 65, 458–465 (1999).

  12. 12

    Marcuzzi, A., Weinberger, J. & Weinberger, O.K. Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes. J. Virol. 66, 4228–4232 (1992).

  13. 13

    Milani, D. et al. Influence of the human immunodeficiency virus type 1 Tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells. J. Gen. Virol. 74, 2587–2594 (1993).

  14. 14

    Kolson, D.L. et al. HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Res. Hum. Retroviruses 9, 677–685 (1993).

  15. 15

    Barillari, G., Gendelman, R., Gallo, R.C. & Ensoli, B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90, 7941–7945 (1993).

  16. 16

    Strickland, D.K., Kounnas, M.Z. & Argraves, W.S. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 9, 890–898 (1995).

  17. 17

    Krieger, M. & Herz, J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63, 601–637 (1994).

  18. 18

    Rhim, H., Echetebu, C.O., Herrmann, C.H. & Rice, A.P. Wild-type and mutant HIV-1 and HIV-2 Tat proteins expressed in Escherichia coli as fusions with glutathione S-transferase. J. Acquir. Immune Defic. Syndr. 7, 1116–1121 (1994).

  19. 19

    Bu, G. & Rennke, S. Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein. J. Biol. Chem. 271, 22218–22224 (1996).

  20. 20

    Mann, D.A. & Frankel, A.D. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10, 1733–1739 (1991).

  21. 21

    Rusnati, M. et al. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. J. Biol. Chem. 272, 11313–11320 (1997).

  22. 22

    FitzGerald, D.J. et al. Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein. J. Cell Biol. 129, 1533–1541 (1995); erratum 130, 1015 (1995).

  23. 23

    Esko, J.D., Rostand, K.S. & Weinke, J.L. Tumor formation dependent on proteoglycan biosynthesis. Science 241, 1092–1096 (1988).

  24. 24

    Westendorp, M.O. et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375, 497–500 (1995).

  25. 25

    Howard, G.C., Misra, U.K., DeCamp, D.L. & Pizzo, S.V. Altered interaction of Cis-dichlorodiammineplatinum(II)—modified α2-macroglobulin (α2M) with the low density lipoprotein receptor-related protein/α2M receptor but not the α2M signaling receptor. J. Clin. Invest. 97, 1193–1203 (1996).

  26. 26

    Narita, M., Holtzman, D.M., Schwartz, A.L. & Bu, G. Alpha2-macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor- related protein. J. Neurochem. 69, 1904–1911 (1997).

  27. 27

    Raghavan, R. et al. Neuropathogenesis of chimeric simian/human immunodeficiency virus infection in pig-tailed and rhesus macaques. Brain Pathol. 7, 851–861 (1997).

  28. 28

    Kruman, I.I. et al. Evidence that Par-4 participates in the pathogenesis of HIV encephalitis. Am. J. Pathol. 155, 39–46 (1999).

  29. 29

    Hudson, L. et al. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J. Neurovirol. 6, 145–155 (2000).

  30. 30

    Liu, Z.Q. et al. Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques. Virology 260, 295–307 (1999).

  31. 31

    Kang, J. et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733–736 (1987).

  32. 32

    Masters, C.L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245–4249 (1985).

  33. 33

    Bu, G., Maksymovitch, E.A., Nerbonne, J.M. & Schwartz, A.L. Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J. Biol. Chem. 269, 18521–18528 (1994).

  34. 34

    Higuchi, M. et al. Expression of the α2-macroglobulin-encoding gene in rat brain and cultured astrocytes. Gene 141, 155–162 (1994).

  35. 35

    Mouchel, Y., Lefrancois, T., Fages, C. & Tardy, M. Apolipoprotein E gene expression in astrocytes: developmental pattern and regulation. Neuroreport 7, 205–208 (1995).

  36. 36

    Banati, R.B. et al. Early and rapid de novo synthesis of Alzheimer β A4-amyloid precursor protein (APP) in activated microglia. Glia 9, 199–210 (1993).

  37. 37

    Higgins, L.S., Rodems, J.M., Catalano, R., Quon, D. & Cordell, B. Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751. Proc. Natl. Acad. Sci. USA 92, 4402–4406 (1995).

  38. 38

    Sturchler-Pierrat, C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 994, 13287–13292 (1997).

  39. 39

    Giometto, B. et al. Accumulation of β-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann. Neurol. 42, 34–40 (1997).

  40. 40

    An, S.F. et al. Axonal damage revealed by accumulation of β-APP in HIV-positive individuals without AIDS. J. Neuropathol. Exp. Neurol. 56, 1262–1268 (1997).

  41. 41

    Raja, F., Sherriff, F.E., Morris, C.S., Bridges, L.R. & Esiri, M.M. Cerebral white matter damage in HIV infection demonstrated using beta- amyloid precursor protein immunoreactivity. Acta Neuropathol. (Berl) 93, 184–189 (1997).

  42. 42

    Kounnas, M.Z. et al. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82, 331–340 (1995).

  43. 43

    Magnuson, D.S., Knudsen, B.E., Geiger, J.D., Brownstone, R.M. & Nath, A. Human immunodeficiency virus type 1 tat activates non-N-methyl-D- aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37, 373–380 (1995).

  44. 44

    Fields, S. & Sternglanz, R. The two-hybrid system: an assay for protein-protein interactions. Trends Genet. 10, 286–292 (1994).

  45. 45

    Sodroski, J. et al. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science 227, 171–173 (1985).

Download references


We thank C. Herrmann for advice on the GST–Tat protein purification, and H. Broxmeyer, S. Spinola, J. Blum, Y.-C. Yang, A. Srivastava and G. Alkhatib for critical reading of the manuscript. This work was supported by grants from Indiana University School of Medicine and the Ralph W. and Grace M. Showalter Trust Foundation, and funds from Department of Microbiology and Immunology and Walther Oncology Center at Indiana University School of Medicine, and the grant NS39253 (to AN).

Author information

Correspondence to Johnny J. He.

Rights and permissions

Reprints and Permissions

About this article

Further reading

Figure 1: Interaction of Tat with neurons.
Figure 2: Specific interaction of Tat and LRP.
Figure 3: Neuronal uptake of Tat mediated by LRP.
Figure 4: Competitive inhibition of interaction between LRP and LRP ligands by Tat.
Figure 5: Immunostaining for APP and Tat in the brains of SHIV-infected macaques.